Literature DB >> 24786976

Regulatory neuropeptides (ghrelin, obestatin and nesfatin-1) levels in serum and reproductive tissues of female and male rats with fructose-induced metabolic syndrome.

Zekiye Catak1, Suleyman Aydin2, Ibrahim Sahin3, Tuncay Kuloglu4, Aziz Aksoy5, Adile Ferda Dagli6.   

Abstract

Although, the exact mechanisms underlying the development of the metabolic syndrome (MetS) are not still completely understood, obesity, circulated peptide hormone levels and their interaction with genetic factors are considered largely responsible. The purpose of this study is to explore how the levels of ghrelin, obestatin (OBS) and NUCB2/nesfatin-1 (NES)/NUCB2 change in serum and the reproductive tissues of female and male rats with fructose-induced metabolic syndrome, and whether the levels of each hormone is correlated with the hormones involved with fertility. Experiments were conducted on 5-week-old Sprague-Dawley male and female rats assigned to either a control group or a MetS group. Controls were fed standard rat food and water ad libitum, while the MetS group was fed standard food with 10% (v/v) fructose solution added to their drinking water for 12 weeks with a 12/12h photoperiod circle. Then, all animals were sacrificed after a one night fast. Peptides levels in the serum and reproductive tissues of rats were studied using the ELISA method while the immunoreactivity of reproductive system peptide hormones were shown by immunohistochemical staining method. Furthermore, the other biochemical parameters were measured using Konelab-60 equipment and infertility hormones were measured with Immulite2000. Fasting serum insulin, glucose, triglyceride, alanine aminotransferase (ALT), gamma glutamyl transpeptidase (GGT), low-density lipoprotein cholesterol (LDL-C), and total cholesterol (TC) levels were statistically significantly higher, and the amount of high density lipoprotein cholesterol (HDL-C) was significantly lower, in the MetS groups. Serum and tissue supernatant NES levels were significantly higher in the rats with MetS than the control group. Ghrelin, OBS and NES were expressed in the cytoplasm, concentrated around the apical parts of the epithelial cells in the reproductive tissues of the rats. The amounts of ghrelin were lower in the reproductive tissues of the animals with MetS, while NES levels in the same tissues increased. Obestatin also decreased, though not in the seminal glands.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ghrelin; Infertility; Metabolic syndrome; NUCB2/nesfatin-1; Obestatin

Mesh:

Substances:

Year:  2014        PMID: 24786976     DOI: 10.1016/j.npep.2014.04.002

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  10 in total

Review 1.  Regulatory Peptide Nesfatin-1 and its Relationship with Metabolic Syndrome.

Authors:  Tuba Tekin; Betul Cicek; Nurefsan Konyaligil
Journal:  Eurasian J Med       Date:  2019-08-19

2.  Expression and function of nesfatin-1 are altered by stage of the estrous cycle.

Authors:  Alicia T Pate; Abigayle L Schnell; Teresa A Ennis; Willis K Samson; Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-29       Impact factor: 3.619

3.  Therapeutic Efficacy of Aerobic Exercise Training along with Oak Husk Hydroalcoholic Extract for Amelioration of Inflammation in Obese Elderly Male Mice.

Authors:  Iman Zakavi; Shila Nayebifar; Elham Ghasemi; Aliasghar Valipour
Journal:  Biomed Res Int       Date:  2021-05-03       Impact factor: 3.411

4.  Treatment of lean and diet-induced obesity (DIO) mice with a novel stable obestatin analogue alters plasma metabolite levels as detected by untargeted LC-MS metabolomics.

Authors:  Brian D Green; Stewart F Graham; Elaine Cowan; Praveen Kumar; Kerry J Burch; David J Grieve
Journal:  Metabolomics       Date:  2016-07-05       Impact factor: 4.290

Review 5.  Adropin- A Novel Biomarker of Heart Disease: A Systematic Review Article.

Authors:  Somaye Yosaee; Sepideh Soltani; Eghbal Sekhavati; Shima Jazayeri
Journal:  Iran J Public Health       Date:  2016-12       Impact factor: 1.429

6.  Nesfatin-130-59 Injected Intracerebroventricularly Increases Anxiety, Depression-Like Behavior, and Anhedonia in Normal Weight Rats.

Authors:  Stephanie Gladys Kühne; Martha Anna Schalla; Tiemo Friedrich; Peter Kobelt; Miriam Goebel-Stengel; Melissa Long; Marion Rivalan; York Winter; Matthias Rose; Andreas Stengel
Journal:  Nutrients       Date:  2018-12-03       Impact factor: 5.717

7.  Modulatory effects of ghrelin on sperm quality alterations induced by a fructose-enriched diet.

Authors:  Nicolás David Ramírez; Eugenia Mercedes Luque; Xaviar Michael Jones; Pedro Javier Torres; María José Moreira Espinoza; Verónica Cantarelli; Marina Flavia Ponzio; Ana Arja; María Belén Rabaglino; Ana Carolina Martini
Journal:  Heliyon       Date:  2019-11-20

8.  Ghrelin protects the myocardium with hypoxia/reoxygenation treatment through upregulating the expression of growth hormone, growth hormone secretagogue receptor and insulin-like growth factor-1, and promoting the phosphorylation of protein kinase B.

Authors:  Yang Liu; Yanling Liu; Guolin Li; Zhengrong Chen; Guixiong Gu
Journal:  Int J Mol Med       Date:  2018-09-18       Impact factor: 4.101

9.  Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.

Authors:  Seyed Ali Jazayeri-Tehrani; Seyed Mahdi Rezayat; Siavash Mansouri; Mostafa Qorbani; Seyed Moayed Alavian; Milad Daneshi-Maskooni; Mohammad-Javad Hosseinzadeh-Attar
Journal:  Nutr Metab (Lond)       Date:  2019-01-28       Impact factor: 4.169

10.  NUCB2/Nesfatin-1 in the Blood and Follicular Fluid in Patients with Polycystic Ovary Syndrome and Poor Ovarian Response.

Authors:  Zekiye Catak; Seyda Yavuzkir; Esra Kocdemir; Kader Ugur; Meltem Yardim; İbrahim Sahin; Esra Piril Agirbas; Suleyman Aydin
Journal:  J Reprod Infertil       Date:  2019 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.